Literature DB >> 11874869

Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts.

Shusaku Haranaga1, Hideaki Ikejima, Hiroyuki Yamaguchi, Herman Friedman, Yoshimasa Yamamoto.   

Abstract

Chlamydia pneumoniae is an obligate intracellular bacterium and has a unique development cycle consisting of an elementary body (EB) and reticular body (RB). EBs survive in extracellular environments as well as infect susceptible host cells. However, EBs display no measurable metabolic activity. In contrast, RBs are metabolically active and can replicate in a host cell but are noninfectious. Therefore, analysis of C. pneumoniae growth in infected cells by conventional bacterial culture may not permit sufficient information about growth of the bacteria in cells. In this study, therefore, we examined the usefulness of the reverse transcription (RT)-PCR method for analysis of bacterial transcripts to evaluate C. pneumoniae growth in HEp-2 cells because the levels of bacterial gene transcripts are known to show the metabolic activity of bacteria. The transcripts for the C. pneumoniae hsp60 gene and 16S rRNA in the cells were easily detected just after infection, followed by a marked increase. In contrast, pyk and omcB transcripts slowly increased after a latent period. The hydrocortisone treatment of C. pneumoniae-infected cells induced an increase of all bacterial transcripts tested compared with the control group. The treatment of the infected cells with the antibiotic minocycline showed a selective inhibition of bacterial gene transcripts, even though the complete inhibition of EB production determined by the bacterial culture assay was evident. These results indicate that the determination of bacterial gene transcripts by RT-PCR might be a powerful method to analyze in detail growth of C. pneumoniae in host cells, particularly altered bacterial growth caused by agents such as antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874869      PMCID: PMC119931          DOI: 10.1128/cdli.9.2.313-319.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  30 in total

1.  mRNA detection by reverse transcription-PCR for monitoring viability over time in an Enterococcus faecalis viable but nonculturable population maintained in a laboratory microcosm.

Authors:  M M Lleò; S Pierobon; M C Tafi; C Signoretto; P Canepari
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  The physiological disposition and metabolic fate of hydrocortisone in man.

Authors:  R E PETERSON; J B WYNGAARDEN; S L GUERRA; B B BRODIE; J J BUNIM
Journal:  J Clin Invest       Date:  1955-12       Impact factor: 14.808

Review 3.  Chlamydia pneumoniae, strain TWAR.

Authors:  J T Grayston
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

4.  Chlamydia pneumoniae present in the human synovium are viable and metabolically active.

Authors:  H C Gérard; H R Schumacher; H El-Gabalawy; R Goldbach-Mansky; A P Hudson
Journal:  Microb Pathog       Date:  2000-07       Impact factor: 3.738

5.  Biosynthesis and disulfide cross-linking of outer membrane components during the growth cycle of Chlamydia trachomatis.

Authors:  W J Newhall
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Cellular immunity after intravenous administration of methylprednisolone.

Authors:  M L Webel; R E Ritts; H F Taswell; J V Danadio; J E Woods
Journal:  J Lab Clin Med       Date:  1974-03

7.  Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.

Authors:  E I Shaw; C A Dooley; E R Fischer; M A Scidmore; K A Fields; T Hackstadt
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

8.  Structural and polypeptide differences between envelopes of infective and reproductive life cycle forms of Chlamydia spp.

Authors:  T P Hatch; I Allan; J H Pearce
Journal:  J Bacteriol       Date:  1984-01       Impact factor: 3.490

9.  Interaction of L cells and Chlamydia psittaci: entry of the parasite and host responses to its development.

Authors:  R R Friis
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

10.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

View more
  8 in total

1.  Chlamydia pneumoniae resists antibiotics in lymphocytes.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Mayumi Yamamoto; Keigo Yasuda; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

2.  Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion.

Authors:  Hideaki Ikejima; Herman Friedman; German F Leparc; Yoshimasa Yamamoto
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

4.  An improved method on isolation and serial passage of Chlamydia pneumoniae from human peripheral blood mononuclear cells.

Authors:  Qian Jin; Feihua Huang; Shuming Sun; Ying Zhou; Xianrong Xu; Weixing Xi
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

5.  Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of σ66.

Authors:  Xiaofeng Bao; Bryce E Nickels; Huizhou Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

6.  Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Authors:  Riho Takano; Hiroyuki Yamaguchi; Shigehiro Sugimoto; Shinichi Nakamura; Herman Friedman; Yoshimasa Yamamoto
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

7.  Transcriptional response patterns of Chlamydophila psittaci in different in vitro models of persistent infection.

Authors:  Stefanie Goellner; Evelyn Schubert; Elisabeth Liebler-Tenorio; Helmut Hotzel; Hans Peter Saluz; Konrad Sachse
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells.

Authors:  Hiroyuki Yamaguchi; Herman Friedman; Yoshimasa Yamamoto
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.